Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressDividends payablesGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityMinority InterestNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (NHPBP) Land & Improvements (2016 - 2025)

Historic Land & Improvements for National Healthcare Properties (NHPBP) over the last 13 years, with Q3 2025 value amounting to $176.5 million.

  • National Healthcare Properties' Land & Improvements fell 1090.93% to $176.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.5 million, marking a year-over-year decrease of 1090.93%. This contributed to the annual value of $190.1 million for FY2024, which is 860.87% down from last year.
  • National Healthcare Properties' Land & Improvements amounted to $176.5 million in Q3 2025, which was down 1090.93% from $178.0 million recorded in Q2 2025.
  • National Healthcare Properties' 5-year Land & Improvements high stood at $214.1 million for Q1 2021, and its period low was $176.5 million during Q3 2025.
  • Moreover, its 5-year median value for Land & Improvements was $206.5 million (2021), whereas its average is $201.7 million.
  • Its Land & Improvements has fluctuated over the past 5 years, first soared by 254.27% in 2023, then plummeted by 1463.78% in 2025.
  • Over the past 5 years, National Healthcare Properties' Land & Improvements (Quarter) stood at $206.4 million in 2021, then increased by 0.03% to $206.5 million in 2022, then increased by 0.74% to $208.0 million in 2023, then dropped by 8.61% to $190.1 million in 2024, then decreased by 7.14% to $176.5 million in 2025.
  • Its Land & Improvements stands at $176.5 million for Q3 2025, versus $178.0 million for Q2 2025 and $182.7 million for Q1 2025.